文献速递肾移植肾小球疾病

美国儿童肾移植受者中FSGS患者死亡率与移植物丢失趋势

Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
PubMed 文献 · Am J Kidney Dis · 2017-12-23

该回顾性队列研究基于USRDS数据库,纳入1990-2009年首次肾移植的12,303例儿童患者(其中FSGS 1,408例),随访至2015年6月。结果显示,与1990年代相比,2000年代移植的FSGS患者全因死亡率显著改善(HR 0.55),移植物丢失率降低幅度较小(HR 0.85);校正基线特征后,FSGS患者死亡率与非FSGS患者相似,但移植物丢失率更高;进一步校正移植物失败后,2000年代FSGS患者死亡率低于非FSGS患者。

要点

  • 2000年代移植的FSGS儿童患者全因死亡率较1990年代显著改善(HR 0.55,95%CI 0.39-0.78)。
  • FSGS儿童患者移植物丢失率仍高于非FSGS患者(HR 1.17-1.27),降低幅度有限。
  • 减少疾病复发所致移植物丢失可能改善FSGS儿童患者的生存。

核心结论

  • 儿童FSGS肾移植受者生存率在1990年代至2000年代间改善,且与非FSGS受者相似。
  • 校正移植物失败后,2000年代FSGS患者生存率高于非FSGS患者。

研究设计与样本

  • 回顾性队列研究,纳入USRDS数据库中1990-2009年首次肾移植的12,303例儿童患者(年龄<18岁),其中FSGS 1,408例(11%),随访至2015年6月。

主要发现

  • FSGS患者2000年代移植较1990年代全因死亡率显著改善(6.72 vs 12.24 deaths/1,000 patient-years;HR 0.55,95%CI 0.39-0.78,P<0.001)。
  • FSGS患者移植物丢失率降低幅度较小(75.91 vs 89.05 events/1,000 patient-years;HR 0.85,95%CI 0.74-0.98,P=0.02)。
  • 校正基线特征后,FSGS患者死亡率与非FSGS患者相似(2000年代HR 0.81,P=0.6;1990年代HR 1.06,P=0.2),但移植物丢失率更高(HR 1.17,P=0.03;HR 1.27,P<0.001)。
  • 2000年代移植患者中,进一步校正移植物失败作为时变协变量后,FSGS患者死亡率低于非FSGS患者(HR 0.70,P=0.02)。

临床怎么用

  • 针对儿童FSGS肾移植受者,应重视疾病复发导致的移植物丢失,采取有效干预可能改善患者生存。

局限性

  • 缺乏某些死亡风险因素信息(如慢性肾脏病病程);存在数据缺失;可能存在原发病误分类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pediatric patients with focal segmental glomerulosclerosis (FSGS) have high rates of disease recurrence and allograft failure after kidney transplantation, but there are few data for long-term survival posttransplantation. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 12,303 pediatric patients (aged <18 years), including 1,408 (11%) patients with FSGS, who received a first kidney transplant in 1990 through 2009 and were followed up through June 2015 were identified from the US Renal Data System database. PREDICTORS: Primary cause of end-stage renal disease, FSGS or other. OUTCOMES: All-cause patient mortality and allograft loss. RESULTS: All-cause mortality significantly improved for patients with FSGS who underwent transplantation in the 2000s versus the 1990s (6.72 vs 12.24 deaths/1,000 patient-years; HR, 0.55; 95% CI, 0.39-0.78; P<0.001). Reductions in allograft loss were less dramatic (75.91 vs 89.05 events/1,000 patient-years; HR, 0.85; 95% CI, 0.74-0.98; P=0.02). After adjusting for baseline characteristics at the time of transplantation, patients with FSGS had similar rates of death compared with patients without FSGS (HRs of 0.81 [P=0.6] and 1.06 [P=0.2] among those who underwent transplantation in the 2000s and 1990s, respectively) despite higher rates of allograft loss (HRs of 1.17 [P=0.03] and 1.27 [P<0.001], respectively). Among patients who underwent transplantation in the 2000s, further adjustment for allograft failure as a time-varying covariate demonstrated a lower rate of death among patients with FSGS compared with those without FSGS (HR, 0.70; P=0.02). LIMITATIONS: Lack of information about certain risk factors for mortality, including duration of chronic kidney disease; missing data; and potential primary disease misclassification. CONCLUSIONS: Survival of pediatric kidney transplant recipients with FSGS improved between the 1990s and 2000s and was similar to that of recipients without FSGS. Interestingly, adjustment for allograft failure showed greater survival for pediatric patients with FSGS who underwent transplantation in the 2000s as compared with others, suggesting that effective interventions to decrease allograft loss due to disease recurrence may improve patient survival.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Wang CS, Gander J, Patzer RE, et al. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis. Am J Kidney Dis. 2017. PMID: 29277509. doi:10.1053/j.ajkd.2017.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。